SCALOP-2

Sponsor: University of Oxford

ClinicalTrials.gov Number: NCT02024009

EudraCT number: 2013-004968-56

 

Systemic therapy and Chemoradiation in Advanced LOcalised Pancreatic cancer – 2

Full title: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer

Tim Humphrey

The aim or our research is to understand how genome stability is maintained in response to DNA double-strand breaks, and to exploit our findings to target cancer.

Pages

About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
Research
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.
Subscribe to Department of Oncology RSS